Verastem, Inc. Financing Cash Flow
Verastem, Inc. (VSTM) reported Financing Cash Flow of $27.15 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-06
- Verastem, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$1.54M, a 101.94% decline year-over-year.
- Verastem, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $28.69M, a 57.45% decline year-over-year.
- Verastem, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $98.58M, a 13186.12% increase year-over-year.
- Verastem, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $17.88M, a 66.64% decline year-over-year.
- Verastem, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $263.31M, a 380.64% increase from fiscal 2024.
- Verastem, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $54.78M, a 59.18% decline from fiscal 2023.
- Verastem, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $134.19M, a 159.14% increase from fiscal 2022.
- Verastem, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $51.78M, a 652.13% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $27.15M 10-Q · filed 2026-08-06 | $125.74M derived: sum of 3 quarters · filed 2026-08-06 | $143.62M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $28.69M 10-Q · filed 2026-05-07 | $127.28M derived: sum of 2 quarters · filed 2026-05-07 | $145.15M derived: sum of 3 quarters · filed 2026-05-07 | $224.57M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $98.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $116.46M derived: sum of 2 quarters · filed 2026-03-04 | $195.88M derived: sum of 3 quarters · filed 2026-08-06 | $263.31M 10-K · filed 2026-03-04 |
| 2025-09-30 | $17.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $97.30M derived: sum of 2 quarters · filed 2026-08-06 | $164.72M 10-Q · filed 2025-11-04 | $165.46M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $79.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $146.84M 10-Q · filed 2026-08-06 | $147.59M derived: sum of 3 quarters · filed 2026-08-06 | $201.18M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $67.43M 10-Q · filed 2026-05-07 | $68.17M derived: sum of 2 quarters · filed 2026-05-07 | $121.77M derived: sum of 3 quarters · filed 2026-05-07 | $121.36M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $742.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $54.34M derived: sum of 2 quarters · filed 2026-03-04 | $53.94M derived: sum of 3 quarters · filed 2026-03-04 | $54.78M 10-K · filed 2026-03-04 |
| 2024-09-30 | $53.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $53.19M derived: sum of 2 quarters · filed 2025-11-04 | $54.04M 10-Q · filed 2025-11-04 | $53.59M derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-06-30 | -$405.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $441.00K 10-Q · filed 2025-08-07 | -$5.00K derived: sum of 3 quarters · filed 2026-03-04 | -$896.00K derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-03-31 | $846.00K 10-Q · filed 2025-05-13 | $400.00K derived: sum of 2 quarters · filed 2026-03-04 | -$491.00K derived: sum of 3 quarters · filed 2026-03-04 | $90.99M derived: sum of 4 quarters · filed 2026-03-04 |
| 2023-12-31 | -$446.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$1.34M derived: sum of 2 quarters · filed 2026-03-04 | $90.14M derived: sum of 3 quarters · filed 2026-03-04 | $134.19M 10-K · filed 2026-03-04 |
| 2023-09-30 | -$891.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $90.59M derived: sum of 2 quarters · filed 2024-11-06 | $134.64M 10-Q · filed 2024-11-06 | $134.64M derived: sum of 4 quarters · filed 2025-03-20 |
| 2023-06-30 | $91.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $135.53M 10-Q · filed 2024-08-08 | $135.53M derived: sum of 3 quarters · filed 2025-03-20 | $161.16M derived: sum of 4 quarters · filed 2025-03-20 |
| 2023-03-31 | $44.05M 10-Q · filed 2024-05-09 | $44.05M derived: sum of 2 quarters · filed 2025-03-20 | $69.67M derived: sum of 3 quarters · filed 2025-03-20 | $70.38M derived: sum of 4 quarters · filed 2025-03-20 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $25.62M derived: sum of 2 quarters · filed 2025-03-20 | $26.33M derived: sum of 3 quarters · filed 2025-03-20 | $51.78M 10-K · filed 2025-03-20 |
| 2022-09-30 | $25.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $26.33M derived: sum of 2 quarters · filed 2023-11-08 | $51.78M 10-Q · filed 2023-11-08 | $58.59M derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-06-30 | $708.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $26.16M 10-Q · filed 2023-08-08 | $32.97M derived: sum of 3 quarters · filed 2024-03-14 | $33.13M derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-03-31 | $25.45M 10-Q · filed 2023-05-09 | $32.26M derived: sum of 2 quarters · filed 2024-03-14 | $32.43M derived: sum of 3 quarters · filed 2024-03-14 | $32.91M derived: sum of 4 quarters · filed 2024-03-14 |
| 2021-12-31 | $6.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $6.97M derived: sum of 2 quarters · filed 2024-03-14 | $7.46M derived: sum of 3 quarters · filed 2024-03-14 | $6.88M 10-K · filed 2024-03-14 |
| 2021-09-30 | $169.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $658.00K derived: sum of 2 quarters · filed 2022-11-03 | $80.00K 10-Q · filed 2022-11-03 | -$36.53M derived: sum of 4 quarters · filed 2023-03-14 |
| 2021-06-30 | $489.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$89.00K 10-Q · filed 2022-08-08 | -$36.70M derived: sum of 3 quarters · filed 2023-03-14 | -$36.56M derived: sum of 4 quarters · filed 2023-03-14 |
| 2021-03-31 | -$578.00K 10-Q · filed 2022-05-09 | -$37.18M derived: sum of 2 quarters · filed 2023-03-14 | -$37.05M derived: sum of 3 quarters · filed 2023-03-14 | -$24.37M derived: sum of 4 quarters · filed 2023-03-14 |
| 2020-12-31 | -$36.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$36.47M derived: sum of 2 quarters · filed 2023-03-14 | -$23.79M derived: sum of 3 quarters · filed 2023-03-14 | $69.63M 10-K · filed 2023-03-14 |
| 2020-09-30 | $137.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $12.81M derived: sum of 2 quarters · filed 2021-11-04 | $106.24M 10-Q · filed 2021-11-04 | $93.53M derived: sum of 4 quarters · filed 2022-03-28 |
| 2020-06-30 | $12.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-02 | $106.10M 10-Q · filed 2021-08-02 | $93.39M derived: sum of 3 quarters · filed 2022-03-28 | $93.89M derived: sum of 4 quarters · filed 2022-03-28 |
| 2020-03-31 | $93.42M 10-Q · filed 2021-05-11 | $80.72M derived: sum of 2 quarters · filed 2022-03-28 | $81.21M derived: sum of 3 quarters · filed 2022-03-28 | $90.91M derived: sum of 4 quarters · filed 2022-03-28 |
| 2019-12-31 | -$12.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | -$12.21M derived: sum of 2 quarters · filed 2022-03-28 | -$2.52M derived: sum of 3 quarters · filed 2022-03-28 | -$2.44M 10-K · filed 2022-03-28 |
| 2019-09-30 | $494.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $10.19M derived: sum of 2 quarters · filed 2020-11-09 | $10.26M 10-Q · filed 2020-11-09 | $155.73M derived: sum of 4 quarters · filed 2021-03-18 |
| 2019-06-30 | $9.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $9.77M 10-Q · filed 2020-08-10 | $155.24M derived: sum of 3 quarters · filed 2021-03-18 | $155.31M derived: sum of 4 quarters · filed 2021-03-18 |
| 2019-03-31 | $75.00K 10-Q · filed 2020-05-07 | $145.54M derived: sum of 2 quarters · filed 2021-03-18 | $145.62M derived: sum of 3 quarters · filed 2021-03-18 | $260.94M derived: sum of 4 quarters · filed 2021-03-18 |
| 2018-12-31 | $145.47M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $145.54M derived: sum of 2 quarters · filed 2021-03-18 | $260.86M derived: sum of 3 quarters · filed 2021-03-18 | $261.16M 10-K · filed 2021-03-18 |
| 2018-09-30 | $74.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $115.39M derived: sum of 2 quarters · filed 2019-10-30 | $115.69M 10-Q · filed 2019-10-30 | $162.42M derived: sum of 4 quarters · filed 2020-03-11 |
| 2018-06-30 | $115.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $115.62M 10-Q · filed 2019-08-01 | $162.34M derived: sum of 3 quarters · filed 2020-03-11 | $176.56M derived: sum of 4 quarters · filed 2020-03-11 |
| 2018-03-31 | $299.00K 10-Q · filed 2019-05-09 | $47.02M derived: sum of 2 quarters · filed 2020-03-11 | $61.23M derived: sum of 3 quarters · filed 2020-03-11 | $61.10M derived: sum of 4 quarters · filed 2020-03-11 |
| 2017-12-31 | $46.72M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $60.94M derived: sum of 2 quarters · filed 2020-03-11 | $60.80M derived: sum of 3 quarters · filed 2020-03-11 | $63.18M 10-K · filed 2020-03-11 |
| 2017-09-30 | $14.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $14.07M derived: sum of 2 quarters · filed 2018-11-07 | $16.46M 10-Q · filed 2018-11-07 | $16.46M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-06-30 | -$138.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $2.25M 10-Q · filed 2018-08-08 | $2.25M derived: sum of 3 quarters · filed 2019-03-12 | $2.25M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-03-31 | $2.39M 10-Q · filed 2018-05-03 | $2.39M derived: sum of 2 quarters · filed 2019-03-12 | $2.39M derived: sum of 3 quarters · filed 2019-03-12 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $0.00 derived: sum of 2 quarters · filed 2019-03-12 | -$5.00K 10-K · filed 2019-03-12 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$5.00K 10-Q · filed 2017-11-07 | ||
| 2016-06-30 | -$5.00K 10-Q · filed 2017-08-08 | |||
| 2015-12-31 | $63.59M 10-K · filed 2018-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |